Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Scandoside SCHEMBL29682452 | 1.00 | L3MBTL1 (0.61) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| Scandoside SCHEMBL29426072 | 1.00 | L3MBTL1 (0.61) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL29425962 | 0.92 | L3MBTL1 (0.53) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL31179906 | 0.89 | ELANE (0.60) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL29425898 | 0.88 | ELANE (0.65) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL29425927 | 0.88 | ELANE (0.65) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL20572206 | 0.88 | ELANE (0.65) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| SCHEMBL29896779 | 0.88 | ELANE (0.65) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| Asperulosidic Acid SCHEMBL29459346 | 0.88 | MAPT (0.52) | L3MBTL1MAPTELANEPTPN1MEN1 | |
| Asperulosidic Acid SCHEMBL422107 | 0.88 | MAPT (0.52) | L3MBTL1MAPTELANEPTPN1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | claimed |
| EP-4379068-A1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | Institut National Des Sciences Appliquées De Rouen (FR) | 2024-06-05 | — | — | EP | claimed |
| CN-109629025-A | A kind of coloured anti-bacterial Lyocell fiber and preparation method thereof | 恒天纤维集团有限公司 | 2019-04-16 | — | — | CN | claimed |
| CN-105755067-A | Method for preparing iridoid genin through enzyme membrane reactor | 浙江科技学院 | 2016-07-13 | — | — | CN | claimed |
| CN-103505379-A | Natural hair dye prepared from iridoid and amino acid and hair dyeing method | UNIV SOUTHWEST NATIONALITIES | 2014-01-15 | — | — | CN | claimed |
| CN-102925508-A | Method for preparing iridoid aglycone | ZHEJIANG BIERRUISI BIOLOG TECHNOLOGY CO LTD | 2013-02-13 | — | — | CN | claimed |
| CN-102344474-A | Preparation method of paederia scandens glucoside | SUZHOU BAOZETANG MEDICAL TECH | 2012-02-08 | — | — | CN | claimed |
| CN-101991592-A | Application of paederoside to preparation of analgesic and/or anti-inflammatory medicaments | SHANGHAI YIHUA BIOMEDICINE CO LTD | 2011-03-30 | — | — | CN | claimed |
| CN-101129524-B | Paederia extractive and medical use of the same | YI JIANG | 2010-04-21 | — | — | CN | claimed |
| CN-101129524-A | Paederia extractive and medical use of the same | YI JIANG (CN) | 2008-02-27 | — | — | CN | claimed |
| US-7179287-B2 | Bioreactor mediated recellularization of natural and tissue engineered vascular grafts | BIOSCIENCE CONSULTANTS (US) | 2007-02-20 | — | — | US | claimed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | claimed |
| US-12576097-B2 | Anti-tumor effective component of Hedyotis diffusa, preparation method therefor and use thereof | GUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD. (CN) | 2026-03-17 | — | — | US | disclosed |
| EP-4702037-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | disclosed |
| CN-119033856-A | Traditional Chinese medicine composition for treating ectopic pregnancy, enema and application thereof | 琼海市中医院 | 2024-11-29 | — | — | CN | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
| US-5078750-A | HAIR DYEING BY IRIDOID GLYCOSIDES AND AGLYCONS THEREOF | TOKIWA KANPO PHARMACEUTICAL CO., LTD. (JP) | 1992-01-07 | — | — | US | disclosed |
| EP-0440494-A2 | Hair dyeing | TOKIWA KANPO PHARMACEUTICAL CO., LTD. (JP) | 1991-08-07 | — | — | EP | disclosed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576097-B2 | Anti-tumor effective component of Hedyotis diffusa, preparation method therefor and use thereof | HDGF, HCCS, PYGL | L3MBTL1 2145/4885MAPT 4552/4885ELANE 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.